Introduction: Novel nicotine delivery systems represent an evolving part of the tobacco harm reduction strategy. The pharmacokinetic (PK) profile of nicotine delivered by P3L, a pulmonary nicotine ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback